» Articles » PMID: 37278614

Caenorhabditis Elegans for Research on Cancer Hallmarks

Overview
Journal Dis Model Mech
Specialty General Medicine
Date 2023 Jun 6
PMID 37278614
Authors
Affiliations
Soon will be listed here.
Abstract

After decades of research, our knowledge of the complexity of cancer mechanisms, elegantly summarized as 'hallmarks of cancer', is expanding, as are the therapeutic opportunities that this knowledge brings. However, cancer still needs intense research to diminish its tremendous impact. In this context, the use of simple model organisms such as Caenorhabditis elegans, in which the genetics of the apoptotic pathway was discovered, can facilitate the investigation of several cancer hallmarks. Amenable for genetic and drug screens, convenient for fast and efficient genome editing, and aligned with the 3Rs ('Replacement, Reduction and Refinement') principles for ethical animal research, C. elegans plays a significant role in unravelling the intricate network of cancer mechanisms and presents a promising option in clinical diagnosis and drug discovery.

Citing Articles

Mutations of the Electron Transport Chain Affect Lifespan and ROS Levels in .

osz F, Nazir A, Takacs-Vellai K, Farkas Z Antioxidants (Basel). 2025; 14(1).

PMID: 39857410 PMC: 11761250. DOI: 10.3390/antiox14010076.


Metabolic Adaptations in Cancer and the Host Using Models and Advanced Tools.

Saez-Carrion E, Aguilar-Aragon M, Garcia-Lopez L, Dominguez M, Uribe M Cells. 2024; 13(23).

PMID: 39682725 PMC: 11640731. DOI: 10.3390/cells13231977.


Myeloproliferative Neoplasm-like Mutations of Calreticulin Induce Phenotypes Associated with Calreticulin Dysfunction in .

Guijarro-Hernandez A, Hurtado C, Urizar-Compains E, Ezcurra B, Galiana-Saenz A, Baquero E Int J Mol Sci. 2024; 25(21).

PMID: 39519157 PMC: 11546369. DOI: 10.3390/ijms252111606.


Uncovering the Molecular Pathways Implicated in the Anti-Cancer Activity of the Imidazoquinoxaline Derivative EAPB02303 Using a Model.

Makhoul P, Galas S, Paniagua-Gayraud S, Deleuze-Masquefa C, El Hajj H, Bonnet P Int J Mol Sci. 2024; 25(14).

PMID: 39063027 PMC: 11277376. DOI: 10.3390/ijms25147785.


Functional distinction in oncogenic Ras variant activity in Caenorhabditis elegans.

Lyu H, Chamberlin H Dis Model Mech. 2024; 17(8).

PMID: 38946472 PMC: 11340813. DOI: 10.1242/dmm.050577.


References
1.
Baugh L, Sternberg P . DAF-16/FOXO regulates transcription of cki-1/Cip/Kip and repression of lin-4 during C. elegans L1 arrest. Curr Biol. 2006; 16(8):780-5. DOI: 10.1016/j.cub.2006.03.021. View

2.
Kukhtar D, Rubio-Pena K, Serrat X, Ceron J . Mimicking of splicing-related retinitis pigmentosa mutations in C. elegans allow drug screens and identification of disease modifiers. Hum Mol Genet. 2020; 29(5):756-765. DOI: 10.1093/hmg/ddz315. View

3.
Brantley S, Cotten S, Lamson D, Smith G, Liu R, Williams K . Discovery of small molecule inhibitors for the C. elegans caspase CED-3 by high-throughput screening. Biochem Biophys Res Commun. 2017; 491(3):773-779. PMC: 5590106. DOI: 10.1016/j.bbrc.2017.07.100. View

4.
van der Hoeven D, Truong T, Naji A, Thapa S, Hancock J, van der Hoeven R . Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans. J Vis Exp. 2020; (164). DOI: 10.3791/61788. View

5.
Sulston J, Horvitz H . Post-embryonic cell lineages of the nematode, Caenorhabditis elegans. Dev Biol. 1977; 56(1):110-56. DOI: 10.1016/0012-1606(77)90158-0. View